Detalles de la búsqueda
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37736808
2.
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Eur J Nucl Med Mol Imaging
; 50(12): 3750-3754, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428216
3.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905411
4.
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging
; 50(8): 2537-2547, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36929180
5.
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw
; 21(1): 43-50.e2, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634610
6.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Cancer
; 128(12): 2358-2366, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417563
7.
Radiotherapy in oligometastatic prostate cancer-a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO).
Strahlenther Onkol
; 198(8): 727-734, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364690
8.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Strahlenther Onkol
; 198(8): 683-689, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704054
9.
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 49(4): 1417-1428, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628521
10.
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Eur J Nucl Med Mol Imaging
; 50(1): 218-227, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35984452
11.
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eur J Haematol
; 109(1): 21-30, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35276022
12.
Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life.
J Urol
; 206(5): 1192-1203, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184923
13.
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Strahlenther Onkol
; 197(11): 993-1000, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463814
14.
Radiotherapy in nodal oligorecurrent prostate cancer.
Strahlenther Onkol
; 197(7): 575-580, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914101
15.
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol
; 197(2): 89-96, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301049
16.
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
Eur J Nucl Med Mol Imaging
; 48(12): 3975-3989, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760957
17.
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Strahlenther Onkol
; 196(7): 637-646, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32211942
18.
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Eur J Nucl Med Mol Imaging
; 47(10): 2328-2338, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179961
19.
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
BMC Cancer
; 20(1): 362, 2020 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349700
20.
Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.
Strahlenther Onkol
; 194(5): 435-443, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29349603